XML 71 R55.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Other Operating Income, net - Summary by category (Details) - USD ($) $ in Thousands | 12 Months Ended | 32 Months Ended | 64 Months Ended
--- | --- | --- | ---
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022
Revenue from External Customer [Line Items] |  |  |  |
Research and development tax credits | $ 946 | $ 4,523 |  |
Other income | 10 | 0 |  |
Other operating income | 1,001 | 14,416 |  |
BARDA |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Funding/Grant income | 0 | 8,085 |  | $ 59,203
CARB-X |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Funding/Grant income | $ 45 | $ 1,808 | $ 2,920 |

X
- Definition Grant Funding Arrangement, Income Earned + References No definition available. + Details
Name: | smmt_GrantFundingArrangementIncomeEarned
Namespace Prefix: | smmt_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Other Operating Income, Other + References No definition available. + Details
Name: | smmt_OtherOperatingIncomeOther
Namespace Prefix: | smmt_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research And Development, Tax Credit + References No definition available. + Details
Name: | smmt_ResearchAndDevelopmentTaxCredit
Namespace Prefix: | smmt_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_OtherOperatingIncome
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=smmt_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=smmt_CombatingAntibioticResistantBacteriaBiopharmaceuticalAcceleratorProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |